The Hidden Price Tag of Cannabis Prohibition in 2026

Photo by MART PRODUCTION via Pexels.

Twelve billion euros. That's what the EU Drugs Agency says Europeans spend every year on cannabis they buy outside any regulated system, according to its 2025 Drug Report -- a figure that hasn't budged much even as country after country loosens its laws. By 2026, something close to 50 countries have legalized cannabis in some form, serving an estimated 230 million people through legal channels. Reform has momentum. And yet in the countries still holding the line, the bill for enforcement keeps arriving anyway -- in police overtime, in clogged court dockets, in tax revenue that never gets collected because the transaction happened in cash, off the books, with no regulator anywhere near it.

Germany's cannabis trade association did what most governments haven't bothered to: it put a number on that bill. €4.7 billion. That figure -- covering everything from freed-up police hours to uncollected tax -- makes Germany the closest thing to a controlled experiment in what prohibition actually costs a modern economy, and what's left on the table when a country only partially steps away from it. This isn't an argument about whether cannabis should be legal on moral or health grounds. It's a much narrower question: what are governments choosing to spend money chasing, when they could be collecting money instead?

Europe's €12 Billion Illicit Market Problem

Photo by Javid Hashimov via Pexels.

The European Union Drugs Agency's 2025 report puts a hard number on something policymakers have talked around for years: the continent's illicit cannabis market is worth roughly €12.1 billion annually. That's not a shrinking figure tied to some outdated black-market economy -- it's current, and it persists despite a wave of legalization that has swept through nearly 50 countries worldwide by 2026, collectively serving something like 230 million consumers through legal, regulated channels. Europe has its own legal market too, and it's growing fast -- from €516 million in 2023 to roughly €1.5 billion in 2025, essentially tripling in two years. On paper that looks like real displacement of the illicit trade. It isn't, at least not yet. A market that grew by a billion euros barely dents a black market worth twelve times that. The math here matters: legal cannabis sales in Europe would need to grow several more multiples just to approach parity with what's still moving through unregulated channels, let alone displace it outright. What this gap exposes is a structural problem with how many European countries have approached reform -- decriminalization here, medical access there, small home-grow allowances somewhere else, but rarely a full regulated supply chain that can actually compete on price, convenience and product consistency with an entrenched illicit market. Partial legalization, it turns out, doesn't automatically starve the black market -- it just adds a smaller, legal option next to it. Consumers who've bought from the same dealer for a decade don't necessarily switch because a pharmacy three towns over now stocks flower. That's precisely the setup that makes Germany worth examining closely: it's gone further than most of its neighbors toward full adult-use legalization, and it still hasn't closed that gap. If a country with Germany's regulatory ambition and market size can't fully displace its illicit trade, that's a signal worth taking seriously across the rest of the continent.

Germany's €4.7 Billion Reckoning

Photo by Osviel Rodriguez Valdés via Pexels.

The German Cannabis Business Association -- known by its German acronym BvCW -- did the arithmetic that most national governments have avoided doing publicly: what would full legal adult-use sales actually be worth to the state, in savings and revenue combined? Their answer is €4.7 billion a year. The breakdown is specific enough to be useful rather than just aspirational. €1.36 billion comes from law enforcement savings alone -- €1.1 billion in police operational costs no longer spent chasing cannabis cases, and another €313 million freed up across prosecutors' offices and courts that would otherwise be processing possession and low-level trafficking cases. The remaining roughly €2.8 billion comes from tax revenue on legal sales, money that currently flows to illicit dealers and untaxed cultivation instead of the federal budget. Germany partially legalized adult-use cannabis in 2024, permitting home cultivation and non-commercial cannabis clubs, but stopped well short of commercial retail sales. The result is that most German consumers are still buying from the same unregulated sources they always did -- meaning the bulk of that €4.7 billion remains theoretical rather than collected. The second interim report from Germany's EKOCAN research consortium, published in April 2026, offers the clearest look yet at what's actually shifted. Home cultivation jumped roughly 300% since the 2024 reform took effect, evidence that Germans are responding to legal pathways when they exist. Youth use rates, meanwhile, held essentially stable -- undercutting one of the more common arguments against loosening cannabis law. And police workforce data within EKOCAN shows measurable hours freed up from cannabis enforcement even under this partial model, well before any commercial retail system exists. Germany, in other words, has already proven the savings side of the ledger works even in a half-built system. What it hasn't proven yet is that a partial model can capture the tax revenue side, because that requires the commercial retail infrastructure the country still hasn't built.

Japan's Hardline Turn Creates a New Cost Category

Photo by Ayyeee Ayyeee via Pexels.

Japan moved in the opposite direction. A revised Cannabis Control Act took effect on December 12, 2024, closing what had been a long-standing gap in Japanese drug law: for decades, the statute criminalized possession and sale of cannabis but left simple use itself unpunished, a quirk that dated back to the law's postwar drafting. That loophole is gone. Cannabis and THC are now formally classified as narcotics under Japanese law, and use on its own -- not just possession or distribution -- carries a prison sentence of up to seven years. The law didn't stay theoretical for long. In March 2025, Tokyo authorities made what appear to be the first use-based arrests under the revised statute, built on urine tests that detected cannabis metabolites in suspects who had no drugs in their possession at the time of arrest. That's a meaningful shift in evidentiary standards -- Japanese police can now build a case entirely on what's metabolized in someone's body, with no product, sale or distribution involved at all. This creates a cost category that essentially didn't exist before: the ongoing expense of testing, prosecuting and incarcerating people for use alone, something Japan's justice system has no historical budget line for and no comparable dataset to project against. Where Germany is trying to measure what it saves by stepping back from enforcement, Japan is about to find out what it costs to expand it -- more lab testing capacity, more court time, more custodial sentences for a category of offense that simply didn't generate arrests before December 2024. Japan's cannabis enforcement was already strict by international standards; this closes the one gap that existed in an otherwise comprehensive prohibition regime. It's the clearest available example of a country betting that tighter enforcement is worth its fiscal cost, at a moment when a growing number of its peers are betting the opposite way.

The UK's Fiscal Argument Nobody in Government Is Making

Photo by Gianluca Pugliese via Pexels.

Britain has the Germany case study sitting right next door, and its own Parliament has noticed. Cross-party parliamentary groups have pushed for formal evidence reviews of UK drug policy, and when they make the argument, Germany's numbers are the ones they cite -- the fiscal breakdown, the EKOCAN youth-use data, the police-hours savings. The pitch from reform advocates isn't subtle: regulation would generate tax revenue the Treasury currently forgoes entirely, it would undercut the illicit supply chains that dominate UK cannabis sales, and it would let regulators actually enforce product safety standards on something currently produced with zero oversight. None of that has moved the government elected in 2024. Labour has been explicit that it has no plans to reform recreational cannabis legislation, evidence reviews or no evidence reviews. That makes the UK a useful counterpoint precisely because it isn't a country lacking information -- it's a country with the same evidence base as Germany, on the same continent, arriving at a different political choice. It's worth being precise about what's actually different: this isn't a UK government disputing Germany's numbers or presenting contrary data. It's a government declining to engage with the fiscal argument at all, treating cannabis reform as politically unwelcome regardless of what the spreadsheet says. Meanwhile enforcement in the UK continues exactly as it did before -- police time, court dockets, the usual costs -- with no BvCW-style domestic accounting to show what any of it amounts to in pounds. Nobody in Whitehall has published the UK's equivalent of that €4.7 billion figure, which means the debate in Britain is currently happening with half the information Germany has generated about itself. That absence is itself informative: it's hard to make a fiscal case for change when no one in government has bothered to calculate what the status quo costs.

California's $227 Million Reminder That Legalization Doesn't End Enforcement Costs

Photo by peterperhac via Pixabay.

California is worth a look precisely because it complicates the tidy story that legalization simply ends enforcement spending. Governor Gavin Newsom announced $227 million in state funding aimed at illegal cannabis activity, community safety programs and public health initiatives, drawn through Proposition 64 grant funding -- the same law that legalized adult-use cannabis in the state back in 2016. Eight years into legalization, with a mature licensed retail industry, taxed cultivation, and a regulatory agency overseeing the whole supply chain, California is still spending nine figures a year fighting an illicit market that keeps operating in parallel. Why does that persist? Mostly price. California's legal cannabis carries state and local taxes, testing and compliance costs, and licensing overhead that unlicensed grows and sales simply don't carry, which means the illicit product often undercuts legal shelf prices by a wide margin -- enough that a meaningful share of California consumers still buy outside the regulated system even with a legal option sitting in a storefront down the street. That's the cautionary data point for Germany and for anyone assuming legalization is a one-time fix that zeroes out the illicit market on its own. It doesn't. It shifts what enforcement is aimed at -- from arresting individual users and small-scale possession cases toward targeting large illegal grow operations and unlicensed distribution networks that specifically compete with the legal market on price -- but it doesn't make that spending line disappear. For countries watching from outside the legalization conversation entirely, California's $227 million is the clearest available signal that the fiscal argument for reform has to be made honestly: legalizing changes what you're spending money enforcing against, not whether you're spending money on enforcement at all.

What the Numbers Actually Add Up To

Germany's cannabis legalization is projected to yield an estimated €4.7 billion fiscal benefit, driven mainly by €2.8 billion in new tax revenue, alongside €1.1 billion in police savings and €0.3 billion in reduced court and prosecution costs.

Put the pieces next to each other and the picture that emerges is incomplete by design -- nobody has actually done the full accounting yet. There's no comprehensive multi-country study tallying a global cost of cannabis prohibition as of 2026. Germany remains the only country with a detailed, published, line-item breakdown of what enforcement costs versus what regulation could recover, which is exactly why it keeps getting cited by reformers everywhere from Westminster to wherever else this debate is happening. Set that €4.7 billion figure against the EU's €12.1 billion illicit-market estimate for Europe as a whole, and the scale of what's still unaddressed becomes obvious -- Germany's number, sizable as it is, describes one country's slice of a continental problem more than twice as large. Japan and the UK sit on either side of that German data point, representing two very different wagers. Japan is spending to tighten enforcement into a category -- use-based prosecution -- that has no prior cost baseline. The UK is spending to maintain an enforcement status quo it hasn't bothered to price out for itself. Neither has published anything resembling Germany's fiscal case, for reform or against it. That absence is the story as much as any of the individual numbers are: policymakers everywhere are choosing sides in a debate that only one country has actually attempted to cost out in public. The chart below lays out Germany's breakdown as the clearest reference point currently available -- the closest thing the global cannabis policy conversation has to a shared unit of measurement.

What Germany has actually done is make prohibition's cost legible in a way it never was before -- a specific, citable, line-itemed number that reform advocates from London to Tokyo can point to instead of gesturing vaguely at "wasted police resources." That's not nothing. But the fact that most German cannabis consumers are still buying from the same unregulated sources they always did, even after the 2024 reform, is the more honest part of the story. Publishing a number and changing where people actually buy their cannabis are two entirely different accomplishments, and Germany has only managed the first one so far.

Japan's tightening and Britain's inertia both suggest something uncomfortable for anyone hoping fiscal arguments settle these debates on their own: they don't, at least not yet. Japan is willing to absorb an entirely new enforcement cost category with no fiscal modeling behind it at all. The UK has the German evidence sitting right there and has chosen not to engage with it. In both cases, political and cultural resistance is outweighing whatever the spreadsheet says -- which tells you these decisions were never really about the spreadsheet to begin with.

The real test is still a few years out. If Germany's EKOCAN data keeps tracking the way it has -- stable youth use, rising home cultivation, freed-up police hours -- and that pattern holds once commercial retail sales actually launch, it becomes much harder for enforcement-heavy countries to argue they simply don't have the evidence. Right now they can still say the data's too new, the sample's too small, the German model's too different from their own. That excuse has a shelf life. Once it expires, the argument left standing won't be about economics at all.